Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 364

1.

Antibodies against deamidated gliadin peptides in early-stage celiac disease.

Kurppa K, Lindfors K, Collin P, Saavalainen P, Partanen J, Haimila K, Huhtala H, Laurila K, Mäki M, Kaukinen K.

J Clin Gastroenterol. 2011 Sep;45(8):673-8. doi: 10.1097/MCG.0b013e3181fbdfa6.

PMID:
21063208
2.

Serological tests in gluten sensitivity (nonceliac gluten intolerance).

Volta U, Tovoli F, Cicola R, Parisi C, Fabbri A, Piscaglia M, Fiorini E, Caio G.

J Clin Gastroenterol. 2012 Sep;46(8):680-5. doi: 10.1097/MCG.0b013e3182372541.

PMID:
22138844
3.

Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study.

Vécsei E, Steinwendner S, Kogler H, Innerhofer A, Hammer K, Haas OA, Amann G, Chott A, Vogelsang H, Schoenlechner R, Huf W, Vécsei A.

BMC Gastroenterol. 2014 Feb 13;14:28. doi: 10.1186/1471-230X-14-28.

4.

Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.

Vitoria JC, Arrieta A, Arranz C, Ayesta A, Sojo A, Maruri N, García-Masdevall MD.

J Pediatr Gastroenterol Nutr. 1999 Nov;29(5):571-4.

PMID:
10554125
5.

Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis.

Volta U, Granito A, Parisi C, Fabbri A, Fiorini E, Piscaglia M, Tovoli F, Grasso V, Muratori P, Pappas G, De Giorgio R.

J Clin Gastroenterol. 2010 Mar;44(3):186-90. doi: 10.1097/MCG.0b013e3181c378f6.

PMID:
20042872
6.

Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.

Rashtak S, Ettore MW, Homburger HA, Murray JA.

Clin Gastroenterol Hepatol. 2008 Apr;6(4):426-32; quiz 370. doi: 10.1016/j.cgh.2007.12.030. Epub 2008 Mar 4.

7.
8.

[Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].

Sabelnikova EA, Parfenov AI, Krums LM, Gudkova RB, Sagynbaeva VE, Bykova SV.

Ter Arkh. 2014;86(2):39-43. Russian.

PMID:
24772506
9.

Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.

Monzani A, Rapa A, Fonio P, Tognato E, Panigati L, Oderda G.

J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):55-60. doi: 10.1097/MPG.0b013e3182145511.

PMID:
21694536
10.

[Predictive value of serological tests in the diagnosis of celiac disease].

Carroccio A, Di Prima L, Falci C, Le Moli C, Soresi M, Montalto G, Notarbartolo A.

Ann Ital Med Int. 2002 Apr-Jun;17(2):102-7. Italian.

PMID:
12150043
11.

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.

Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K.

BMC Immunol. 2008 Feb 29;9:6. doi: 10.1186/1471-2172-9-6.

12.
13.

Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease.

Spatola BN, Kaukinen K, Collin P, Mäki M, Kagnoff MF, Daugherty PS.

Aliment Pharmacol Ther. 2014 Feb;39(4):407-17. doi: 10.1111/apt.12603. Epub 2014 Jan 6.

14.

Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.

Kurppa K, Paavola A, Collin P, Sievänen H, Laurila K, Huhtala H, Saavalainen P, Mäki M, Kaukinen K.

Gastroenterology. 2014 Sep;147(3):610-617.e1. doi: 10.1053/j.gastro.2014.05.003. Epub 2014 May 13.

PMID:
24837306
15.

Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.

Giersiepen K, Lelgemann M, Stuhldreher N, Ronfani L, Husby S, Koletzko S, Korponay-Szabó IR; ESPGHAN Working Group on Coeliac Disease Diagnosis.

J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):229-41. doi: 10.1097/MPG.0b013e318216f2e5. Review.

PMID:
22266486
16.

Early developing celiac disease in children with cerebral palsy.

Stenberg R, Kaukinen K, Bengtsson M, Lindberg E, Dahle C.

J Pediatr Gastroenterol Nutr. 2011 Dec;53(6):674-8. doi: 10.1097/MPG.0b013e318229889d.

PMID:
21697743
17.

Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.

Tosco A, Aitoro R, Auricchio R, Ponticelli D, Miele E, Paparo F, Greco L, Troncone R, Maglio M.

Clin Exp Immunol. 2013 Jan;171(1):69-75. doi: 10.1111/j.1365-2249.2012.04673.x.

18.

Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.

Liu E, Li M, Emery L, Taki I, Barriga K, Tiberti C, Eisenbarth GS, Rewers MJ, Hoffenberg EJ.

J Pediatr Gastroenterol Nutr. 2007 Sep;45(3):293-300.

PMID:
17873740
19.

Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.

Salmi TT, Collin P, Korponay-Szabó IR, Laurila K, Partanen J, Huhtala H, Király R, Lorand L, Reunala T, Mäki M, Kaukinen K.

Gut. 2006 Dec;55(12):1746-53. Epub 2006 Mar 29.

20.

Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.

Olen O, Gudjónsdóttir AH, Browaldh L, Hessami M, Elvin K, Liedberg AS, Neovius M, Grahnquist L.

J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):695-700. doi: 10.1097/MPG.0b013e3182645c54.

PMID:
22722680

Supplemental Content

Support Center